ALKEMAlkem Laboratories

Alkem appoints Grant Thornton for forensic audit of alleged employee fund misappropriation

Alkem Laboratories' audit committee approved an independent forensic investigation into alleged misappropriation of funds by a former employee, linked to procurement transactions.

Price, Wednesday's close₹5,015.00▲ 0.22%
Last 5 days
52-week low ₹4,891.5052-week high ₹5,933.50
Sector
Pharmaceuticals

What happened

  • The audit committee approved the appointment of Grant Thornton Bharat LLP on 21 October to investigate alleged fund misappropriation by a former employee, according to Whalesbook and Sahi.
  • Sahi said the work covers historical procurement transactions and root causes, starting with a preliminary review of electronically stored information and market intelligence.
  • Neither report gave an amount, the former employee's role or any financial impact. Whalesbook published at 9:50 PM on Wednesday and Sahi at 6:03 AM on Thursday.
  • The shares closed at ₹5,015 on Wednesday, per Zerodha Kite, before the disclosure.

Why it matters

The scale of any loss has not been disclosed, so the size of the matter is not yet known from the reports.

Good to know: A forensic audit is an investigation that traces transactions to establish what happened, who was involved and how much money is affected. It is separate from the routine statutory audit.

Key facts

Investigator
Grant Thornton Bharat LLP
Approved by
Audit committee, 21 October 2026
Amount involved
Not disclosed in either report

Read the source

This is a summary of public news about Alkem Laboratories, for information only. It is not a recommendation to buy, sell or hold ALKEM.

Next story · 3 of 3NHPC · NHPCNHPC declares Subansiri Unit 5 commercial from 23 October, lifting capacity to 1,250 MW